 Toshimasa Clark
Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Image Interpretation, Computer-Assisted | 4 | 2017 | 220 | 1.550 |
Why?
| | Radiology Information Systems | 3 | 2019 | 31 | 1.310 |
Why?
| | Contrast Media | 4 | 2019 | 373 | 1.260 |
Why?
| | Thyroid Nodule | 2 | 2019 | 38 | 1.240 |
Why?
| | Magnetic Resonance Angiography | 2 | 2019 | 210 | 1.100 |
Why?
| | Algorithms | 5 | 2019 | 1541 | 1.050 |
Why?
| | Radiology | 3 | 2017 | 199 | 1.030 |
Why?
| | Decision Support Systems, Clinical | 2 | 2017 | 178 | 0.970 |
Why?
| | Incidental Findings | 3 | 2019 | 80 | 0.850 |
Why?
| | Practice Guidelines as Topic | 4 | 2019 | 1440 | 0.820 |
Why?
| | Tomography, X-Ray Computed | 3 | 2016 | 2436 | 0.750 |
Why?
| | Meglumine | 1 | 2019 | 12 | 0.700 |
Why?
| | Adrenocortical Adenoma | 1 | 2019 | 1 | 0.700 |
Why?
| | Multidetector Computed Tomography | 1 | 2019 | 27 | 0.690 |
Why?
| | Organometallic Compounds | 1 | 2019 | 88 | 0.660 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2019 | 81 | 0.640 |
Why?
| | Image Enhancement | 1 | 2019 | 181 | 0.630 |
Why?
| | Sensitivity and Specificity | 6 | 2019 | 1795 | 0.610 |
Why?
| | Radiation Protection | 1 | 2017 | 36 | 0.600 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 81 | 0.580 |
Why?
| | Programming Languages | 1 | 2016 | 24 | 0.580 |
Why?
| | Radiography, Interventional | 1 | 2017 | 113 | 0.570 |
Why?
| | Radiation Dosage | 1 | 2017 | 147 | 0.560 |
Why?
| | Radiologists | 1 | 2016 | 38 | 0.560 |
Why?
| | Gadolinium | 1 | 2016 | 79 | 0.560 |
Why?
| | Data Mining | 1 | 2017 | 113 | 0.550 |
Why?
| | Ultrasonography | 2 | 2019 | 716 | 0.550 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2015 | 19 | 0.550 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 180 | 0.520 |
Why?
| | Blood Flow Velocity | 1 | 2016 | 327 | 0.510 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 109 | 0.510 |
Why?
| | Guideline Adherence | 2 | 2016 | 523 | 0.500 |
Why?
| | Arteries | 1 | 2016 | 250 | 0.490 |
Why?
| | Computer Simulation | 2 | 2016 | 922 | 0.490 |
Why?
| | Mobile Applications | 1 | 2016 | 147 | 0.480 |
Why?
| | Medical Records Systems, Computerized | 1 | 2014 | 92 | 0.470 |
Why?
| | User-Computer Interface | 1 | 2014 | 163 | 0.450 |
Why?
| | Thyroid Neoplasms | 1 | 2016 | 278 | 0.440 |
Why?
| | Quality Improvement | 2 | 2017 | 963 | 0.430 |
Why?
| | Documentation | 1 | 2014 | 175 | 0.430 |
Why?
| | Neoplasms | 2 | 2016 | 2179 | 0.420 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 709 | 0.410 |
Why?
| | Early Detection of Cancer | 1 | 2015 | 360 | 0.400 |
Why?
| | Splenic Diseases | 1 | 2011 | 5 | 0.400 |
Why?
| | Reproducibility of Results | 4 | 2019 | 2874 | 0.370 |
Why?
| | Prostatic Neoplasms | 1 | 2017 | 940 | 0.360 |
Why?
| | Abdominal Injuries | 1 | 2011 | 119 | 0.350 |
Why?
| | Software | 1 | 2014 | 613 | 0.350 |
Why?
| | Spleen | 1 | 2011 | 510 | 0.340 |
Why?
| | Practice Patterns, Physicians' | 1 | 2017 | 1200 | 0.330 |
Why?
| | Thyroid Gland | 2 | 2019 | 84 | 0.310 |
Why?
| | Emergency Service, Hospital | 1 | 2017 | 1864 | 0.280 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3174 | 0.270 |
Why?
| | Software Validation | 2 | 2016 | 7 | 0.270 |
Why?
| | Middle Aged | 7 | 2019 | 27617 | 0.240 |
Why?
| | Liver Neoplasms | 2 | 2019 | 527 | 0.220 |
Why?
| | Humans | 16 | 2020 | 118972 | 0.220 |
Why?
| | Male | 8 | 2019 | 57801 | 0.190 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2020 | 48 | 0.170 |
Why?
| | Adrenocortical Carcinoma | 1 | 2020 | 47 | 0.170 |
Why?
| | Injections, Intravenous | 1 | 2019 | 210 | 0.170 |
Why?
| | Risk Assessment | 2 | 2019 | 3057 | 0.170 |
Why?
| | Female | 9 | 2020 | 61564 | 0.170 |
Why?
| | Artifacts | 1 | 2019 | 125 | 0.160 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2020 | 197 | 0.160 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2019 | 227 | 0.160 |
Why?
| | Famous Persons | 1 | 2017 | 6 | 0.150 |
Why?
| | Retrospective Studies | 3 | 2019 | 12978 | 0.150 |
Why?
| | Tumor Microenvironment | 1 | 2020 | 454 | 0.140 |
Why?
| | Prospective Studies | 2 | 2019 | 6471 | 0.140 |
Why?
| | Neoplasm Grading | 1 | 2017 | 258 | 0.140 |
Why?
| | Observer Variation | 1 | 2017 | 309 | 0.140 |
Why?
| | Efficiency, Organizational | 1 | 2017 | 126 | 0.140 |
Why?
| | Phantoms, Imaging | 1 | 2016 | 139 | 0.140 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2015 | 26 | 0.130 |
Why?
| | Societies, Medical | 1 | 2019 | 703 | 0.130 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2020 | 667 | 0.130 |
Why?
| | Pattern Recognition, Automated | 1 | 2015 | 76 | 0.130 |
Why?
| | Antibodies, Antinuclear | 1 | 2015 | 55 | 0.130 |
Why?
| | Heart Block | 1 | 2015 | 37 | 0.130 |
Why?
| | Sjogren's Syndrome | 1 | 2015 | 40 | 0.130 |
Why?
| | United States | 3 | 2016 | 12555 | 0.130 |
Why?
| | Microcomputers | 1 | 2014 | 13 | 0.120 |
Why?
| | Software Design | 1 | 2014 | 23 | 0.120 |
Why?
| | Biopsy | 1 | 2017 | 1079 | 0.110 |
Why?
| | Information Storage and Retrieval | 1 | 2014 | 124 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2017 | 610 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1384 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1945 | 0.100 |
Why?
| | Aged | 3 | 2019 | 19657 | 0.100 |
Why?
| | Pregnancy Complications | 1 | 2015 | 448 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2017 | 829 | 0.090 |
Why?
| | Disease Models, Animal | 1 | 2020 | 3730 | 0.090 |
Why?
| | Prevalence | 1 | 2016 | 2326 | 0.090 |
Why?
| | Adult | 4 | 2019 | 31512 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2015 | 2220 | 0.050 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 112 | 0.040 |
Why?
| | Mice, Nude | 1 | 2020 | 663 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 874 | 0.040 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2020 | 156 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 740 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1206 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2011 | 9342 | 0.040 |
Why?
| | Immunotherapy | 1 | 2020 | 493 | 0.030 |
Why?
| | Fetal Diseases | 1 | 2015 | 148 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2015 | 227 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 2275 | 0.030 |
Why?
| | Apoptosis | 1 | 2020 | 2484 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6561 | 0.020 |
Why?
| | Mice | 1 | 2020 | 15520 | 0.010 |
Why?
| | Pregnancy | 1 | 2015 | 5690 | 0.010 |
Why?
| | Animals | 1 | 2020 | 33381 | 0.010 |
Why?
|
|
Clark's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|